A study conducted by Peng et al. [55] supported this hypothesis by showing that, in ovarian cancer, paclitaxel can induce tumor cells to overexpress PD-L1 through the NF-κB pathway, thereby promoting the formation of a tumor immunosuppressive microenvironment. The gene discussed is CD274; the disease is ovarian carcinoma.